Pharma

Biography

Dr Sreekala Sreehari is currently the Lead of Centralised Histopathology Laboratory at NMC Royal Hospital, Khalifa City. Currently she is the Country advisor to UAE of Royal College of Pathologists, UK. She is an active member of Pathological Society of Great Britain and Ireland, Europeon Society of Pathology and IAP. She is recently selected as an External peer Assessor to UKAS (United Kingdom Accreditation Services ISO 15189:2012). With more than 10 years of international experience, Dr Sreekala is an expert diagnostician. Her key areas of interests include Oncopathology related to Breast, Colon, Head & Neck, Male & Female Genital system and a core member of NMC Oncocare tumour boards. She is playing a key role in National Cancer Screening Programmes related to Breast, Colon and Cervix in the region. She has authored and co-authored several articles, done audits ad been part of several projects. Early Cancer detection, Digital pathology, Environmental safety, Technology developments in cancer care and Laboratory Quality standards are her main areas of interest. 

Abstract

Breast-cancer is curable if detected early, as well proven by the UK National Breast Cancer

Screening Programme. Developed countries of the world has clear Breast cancer screening guidelines emphasizing Self breast awareness, Clinical Breast Examination and Mammogram algorithms. But in developing countries in the world the situation is not very encouraging. Many cancer detection camps are happening, but they cannot reach larger population. Hence when developed countries significantly reduced their breast cancer mortality rate, in countries like India the mortality rate due to Breast cancer is around 50% (as per latest IARC report). Hence I thought of using smartphone technology for early detection of breast cancer through the BREXA Mobile App. The app has the following features: 1, To score for risk of getting breast cancer; 2, Monthly reminders and video assistance for self breast check, 3, Information about the different tests used in breast cancer diagnosis 4, Once the woman crosses 40 years of age, the app automatically reminds and assist in booking for screening mammogramevery year 5, The results of the tests will be avaible within the App. 6, If the app detects high risk women, such women are given further guidance by expert panel of doctors. 7, Users can also book appointments with doctors and laboratories through the app and avail discounts on mammography 8, Even after diagnosis, guidance and information is available in the app, making it a comprehensive cancer solution.

BREXA is now available in English, Malayalam, Arabic and Hindi. BREXA is completely free and can be downloaded from Google play or App store. It is designed as if a doctor companion is always with the woman giving guidance. With effective use of BREXA app, women world over can be saved from Breast cancer deaths, which is caused due to late detection.

Mission is: ''No more family without a mother due to breast cancer'' ''Save mothers and Save the world''